Kovack Advisors’s LifeMD LFMD Stock Holding History

Kovack Advisors’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10,800	Closed	-$74.1K	–	608
2024 Q2	$74.1K	Buy	+10,800	New	+$98.8K	0.01%	558

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Kovack Advisors's LFMD Position: Q3 2024 in Review

Kovack Advisors sold out of LifeMD (LFMD) in Q3 2024, closing a stake of 10,800 shares — an estimated $74.1K sold.

Kovack Advisors first reported a position in LFMD in Q2 2024 and held it in 1 quarter. The position peaked at $74.1K in Q2 2024. 101 funds tracked by Wall St. Rank hold LFMD as of Q3 2024.

Kovack Advisors reported no remaining LifeMD position as of Q3 2024 after selling out during the quarter.
Kovack Advisors sold 10,800 LifeMD shares in Q3 2024, an estimated $74.1K.
Kovack Advisors first reported a position in LifeMD in Q2 2024 and held it in 1 quarter.
Kovack Advisors's LifeMD position peaked at $74.1K in Q2 2024.
101 funds tracked by Wall St. Rank held LifeMD as of Q3 2024.

Based on Kovack Advisors's 13F filing for Q3 2024, filed 5 Nov 2024.